Capsule with blood sugar reducing function and preparation method thereof

Abstract

The invention discloses a capsule with hypoglycemic action and process for preparation. The invention adopts panax ginseng, astragalus root, siberian solomonseal rhizome, kudzu root, poria cocos wolf, white atractylodes rhizome, schisandra fruit, gardenia, rhubarb horsetails, salvia miltiorrhizae, and glycyrrhiza which are the homology of medicine and food to be raw material. According to different properties and effective components of each raw material, and each raw material is made into capsules with carriers or findings which can be accepted in pharmacy or bromatology after the raw material is respectively disintegrated, extracted and concentrated, and granulated and the like. The invention has the advantages of simple process, easy taking, and significant curative effect, convenient long-term use, and little side effect, which is an ideal hypoglycemic product.

Description

technical field [0001] The invention relates to a capsule with hypoglycemic effect and a preparation method thereof. Background technique [0002] Diabetes is a common endocrine disease, which is called "Xiaoke" in traditional Chinese medicine. It is caused by the absolute or relative lack of insulin in the human body. Urinary, polyphagia, weight loss, and emaciation. Once diabetes is diagnosed, it is necessary to take medicine for life. [0003] Diabetes is the third killer of human health after cardiovascular and cerebrovascular diseases and malignant tumors. According to statistics from 13 research centers such as the World Health Organization (WHO), the International Diabetes Federation (IDF) and the American Diabetes Association (ADA), there are currently 250 million people with diabetes in the world, of which 20% (50 million) are in the China. At the present stage in our country, with the improvement of people's living standards, the quality of diet has also been gr...

AI Technical Summary

Problems solved by technology

[0005] The Maiwei Dihuang Pills recorded in the 2005 edition of the Chinese Pharmacopoeia only have the effect of nourishing the kidney and nourishing the lungs for diabetic lung and kidney yin deficiency, and have no significant effect on diabetic symptoms such as qi deficiency, fatigue, impotence, constipation, blood stasis, etc.; Chinese patent 200410020725.3 has the following defects 1. Because Coptis chinensis is directly used as medicine, Coptidis chinensis is a product of great bitterness and coldness, and long-term use has certain side effects, so it is not suitable for diabetics to take it for a long time; 2. The preparation process is that the ten medicinal materials are simply crushed and then directly made into pills. The process comparison Backward, it is not conducive to the human body to absorb the active ingredients in the medicinal materials, affecting the quality and efficacy of the product